Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis

Oncogene

Volumn 30, Issue 3, 2011, Pages 372-378

  Leclercq, T M ^a,b   Moretti, P A B ^a   Pitson, S M ^a,b  

^a CENTRE FOR CANCER BIOLOGY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

eEF1A; PTI 1; sphingosine 1 phosphate; sphingosine kinase; TCTP

Indexed keywords

ELONGATION FACTOR 1ALPHA; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE; N,N DIMETHYLSPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN 3T3; CELL SURVIVAL; CELL TRANSFORMATION; CHO CELL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; CHO CELLS; CRICETINAE; CRICETULUS; DNA PRIMERS; ENZYME ACTIVATION; GUANINE NUCLEOTIDES; HUMANS; PEPTIDE ELONGATION FACTOR 1; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EUKARYOTA;

EID: 78751649728     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.420     Document Type: Article

References (35)

1. Abbott CM, Proud CG. (2004). Translation factors: in sickness and in health. Trends Biochem Sci 26: 25-31.
2. Al-Maghrebi M, Anim JT, Olalu AA. (2005). Up-regulation of eukaryotic elongation factor-1 subunits in breast carcinoma. Antic-ancer Res 25: 2573-2577.
3. Andersen GR, Nissen P, Nyborg J. (2003). Elongation factors in protein biosynthesis. Trends Biochem Sci 28: 434-441.
4. Andersen GR, Pedersen L, Valente L, Chatterjee I, Kinzy TG, Kjeldgaard M et al. (2000). Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Ba. Mol Cell 6: 1261-1266.
5. Cans C, Passer BJ, Shalak V, Nancy-Portebois V, Crible V, Amzallag N et al. (2003). Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc Natl Acad Sci USA 100: 13892-13897.
6. Cuvillier O. (2008). Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets 12: 1009-1020.
7. Ejiri S. (2002). Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem 66: 1-21.
8. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL et al. (2003). Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63: 5962-5969.
9. Gopalkrishnan RV, Su Z-z, Goldstein NI, Fisher PB. (1999). Translational infidelity and human cancer: role of the PTI-1 oncogene. Int J Biochem Cell Biol 31: 151-162.
10. Hait NC, Oskeritzian CA, Paugh SW, Milstein S, Spiegel S. (2006). Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758: 2016-2026.
11. Kahns S, Lund A, Kristensen P, Knudsen CR, Clark BF, Cavallius J et al. (1998). The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the protein. Nucleic Acids Res 26: 1884-1890.
12. Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Bielawski J et al. (2009). Role for Sphingosine kinase 1 in colon carcinogenesis. FASEB J 23: 405-414.
13. Kohno M, Momoi M, Oo ML, Paik JH, Lee YM, Venkataraman K et al. (2006). Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol 26: 7211-7223.
14. Leclercq T, Morretti PA, Vadas M, Pitson SM. (2008). Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. J Biol Chem 283: 9606-9614.
15. Lee JM. (2003). The role of protein elongation factor eEF1A2 in ovarian cancer. Reprod Biol Endocrinol 1: 69-73.
16. Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. (2005). Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 25: 3117-3126.
17. Mansilla F, Friis I, Jadidi M, Nielsen KM, Clark BF, Knudsen CR. (2002). Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system. Biochem J 365: 669-676.
18. Mansilla F, Hansen LL, Jakobsen H, Kjeldgaard NO, Clark BFC, Knudsen CR. (2005). Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, from of translation elongation factor 1A1, eEF1A1. Biochim Biophys Acta 1727: 116-124.
19. 0skaya AV. (2008). A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules. Int J Biochem Cell Biol 40: 63-71.
20. 0Andrea RJ, Vandeleur L, Moretti PA, Xia P, Gamble JR et al. (2000). Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J Biol Chem 350: 429-441.
21. Pitson SM, Moretti PAB, Zebol JR, Lynn HE, Xia P, Vadas MA et al. (2003). Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 22: 5491-5500.
22. Pitson SM, Moretti PAB, Zebol JR, Zareie R, Derian CK, Darrow AL et al. (2002). The nucleotide-binding site of human sphingosine kinase 1. J Biol Chem 277: 49545-49553.
23. Pitson SM, Xia P, Leclercq TM, Moretti PA, Zebol JR, Lynn HE et al. (2005). Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signaling. J Exp Med 201: 49-54.
24. Roberts JL, Moretti PA, Darrow AL, Derian CK, Vadas MA, Pitson SM. (2004). An assay for sphingosine kinase activity using biotinylated sphingosine and streptavidin-coated membranes. Anal Biochem 331: 122-129.
25. Satoh T, Endo M, Nakafuku M, Nakamura S, Kaziro Y. (1990). Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 87: 5993-5997.
26. Soares DC, Barlow PN, Newbery HJ, Porteous DJ, Abbott CM. (2009). Structural models of human eEF1A1 and eEF1A2 reveal two distinct surface clusters of sequence variation and potential differences in phosphorylation. PLoS One 4: e6315.
27. Sprang SR. (1997). G protein mechanisms: insights from structural biology. Annu Rev Biochem 66: 639-678.
28. Su Z, Goldstein NI, Pisher PB. (1998). Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci USA 95: 1764-1769.
29. Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G et al. (2008). TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ 15: 1211-1220.
30. Taha TA, Hannun YA, Obeid LM. (2006). Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39: 113-131.
31. Thornton S, Anand N, Purcell D, Lee J. (2003). Not just for housekeeping: protein initiation and elongation factors in cell growth and tumourigenesis. J Mol Med 81: 536-548.
32. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Geant A, Beaucourt S et al. (2004). Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA 101: 15364-15369.
33. Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R et al. (2002). Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 99: 14976-14981.
34. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW et al. (2000). An oncogenic role of sphingosine kinase. Curr Biol 10: 1527-1530.
35. Yu L, Wu G, Wang L, Wang H, Zhang G. (2006). Transient reduction of PTI-1 expression by short interfering RNAs inhibits the growth of human prostate cancer cell lines. Tohoku J Exp Med 209: 141-148.